View in EDS

Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes.

Saved in:
Bibliographic Details
Title: Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes.
Authors: Hoppes R; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Oostvogels R; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands Department of Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;, Luimstra JJ; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Wals K; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Toebes M; Division of Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Bies L; Division of Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Ekkebus R; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Rijal P; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Celie PH; Division of Biochemistry, The Netherlands Cancer Institute Protein Facility, 1066 CX Amsterdam, the Netherlands; and., Huang JH; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands., Emmelot ME; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands., Spaapen RM; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Lokhorst H; Department of Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;, Schumacher TN; Division of Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Mutis T; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands., Rodenko B; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, United Kingdom b.rodenko@nki.nl h.ovaa@nki.nl., Ovaa H; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;
Source: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2014 Nov 15; Vol. 193 (10), pp. 4803-13. Date of Electronic Publication: 2014 Oct 13.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 2985117R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1550-6606
DOI:10.4049/jimmunol.1400800